BNY Mellon International Stock Index Fund
- TICKER DIISX
- Fund Code 0079
- CUSIP 09661L500
- SHARE CLASS
-
Literature Download
Why invest in this Fund?
The fund seeks to match the performance of the Morgan Stanley Capital International Europe, Australasia, Far East Free Index (the 'Index'). To pursue this goal, the fund generally is fully invested in stocks included in the Index.
The fund attempts to have a correlation between its performance and that of the Index of at least .95, before expenses. A correlation of 1.00 would mean that the fund and the Index were perfectly correlated.
Morningstar Rating™ as of February 28, 2023 for the Investor Shares class shares; other classes may have different performance characteristics. Overall rating for the Foreign Large Blend category. Fund ratings are out of 5 Stars: Overall 3 Stars (700 funds rated); 3 Yrs. 3 Stars (700 funds rated); 5 Yrs. 3 Stars (614 funds rated); 10 Yrs. 3 Stars (420 funds rated). The Morningstar Rating™ for funds, or "star rating", is calculated for managed products with at least a 3-year history. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance (not including the effects of sales charges, loads and redemption fees if applicable), placing more emphasis on downward variations and rewarding consistent performance. Managed products; including open-end mutual funds, closed-end funds and exchange-traded funds; are considered a single population for comparative purposes. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. © Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results. The fund represents a single portfolio with multiple share classes that have different expense structures. Other share classes may have achieved different results.
Portfolio Managers
-
David France, CFA
Portfolio Manager, Mellon Investments Corporation
2 yr(s). on fund
-
Todd Frysinger, CFA
Portfolio Manager, Mellon Investments Corporation
2 yr(s). on fund
-
Vlasta Sheremeta, CFA
Portfolio Manager, Mellon Investments Corporation
2 yr(s). on fund
-
Michael Stoll
Portfolio Manager, Mellon Investments Corporation
2 yr(s). on fund
-
Marlene Walker Smith
Portfolio Manager, Mellon Investments Corporation
2 yr(s). on fund
Total Returns
Month End
Average Annual As of 02/28/23 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 02/28/23 |
YTD 02/28/23 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon International Stock Index Fund
DIISX |
3.24 | 5.05 | -3.84 | 6.05 | 2.29 | 4.37 | 3.61 |
MSCI EAFE® Index
|
5.93 | 5.84 | -3.14 | 6.84 | 2.64 | 4.83 | - |
Quarter End
Average Annual As of 12/31/22 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 12/31/22 |
YTD 12/31/22 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon International Stock Index Fund
DIISX |
18.28 | -14.55 | -14.55 | 0.60 | 1.26 | 4.18 | 3.44 |
MSCI EAFE® Index
|
17.34 | -14.45 | -14.45 | 0.87 | 1.54 | 4.67 | - |
The MSCI EAFE Index (Europe, Australasia, Far East) is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of developed markets, excluding the U.S. and Canada. Investors cannot invest directly in any index.
Growth of $10,000 Investment
Historical Performance
Yearly Total Return
Yearly
Investment return fluctuates and past performance is no guarantee of future results.
Prospectus Fee Table Expense Ratios
As of 03/01/23 Fee Description | Expense Ratio (%) |
---|---|
Management Fee | 0.35% |
Service Fee | 0.25% |
Other Expenses | 0.01% |
Total Expenses | 0.61% |
Expenses Reimbursed | 0.01% |
Net Expenses | 0.60% |
The fund's investment adviser, BNY Mellon Investment Adviser, Inc. has agreed in its management agreement with the fund to: (1) pay all of the fund's expenses, except management fees, shareholder services plan fees and certain other expenses, including the fees and expenses of the non-interested board members and the fees and expenses of counsel to the fund and to the non-interested board members, and (2) reduce its fee pursuant to the management agreement in an amount equal to the fund's allocable portion of the fees and expenses of the non-interested board members and the fees and expenses of counsel to the fund and to the non-interested board members (in the amount of .01% for the past fiscal year). These provisions in the management agreement may not be amended without the approval of the fund's shareholders.
Portfolio Manager/Sub-Investment Adviser
Asset Allocation
Daily Statistics
As of 03/24/23 Name | NAV | Change |
04/04/22 12 Month High Nav |
09/26/22 12 Month Low Nav |
YTD Return |
---|---|---|---|---|---|
DIISX
|
$17.51 |
-$0.22
-1.24%
|
$18.96 | $14.52 | 4.04% |
Performance Metrics
Overall Morningstar Rating
MORNINGSTAR CATEGORY Foreign Large Blend
Morningstar Rating™ as of 02/28/23 for the Investor Shares shares; other classes may have different performance
characteristics. Overall rating for the Foreign Large Blend. Fund ratings are out of 5 Stars: Overall
3 Stars (700 funds rated); 3 Yrs.
3 Stars (700 funds rated); 5 Yrs.
3 Stars (614 funds rated); 10 Yrs.
3 Stars (420 funds rated).
The
Morningstar Rating™ for funds, or "star rating", is calculated for managed products with at least a 3-year history. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for
variation in a managed product's monthly excess performance (not including the effects of sales charges, loads and redemption fees if applicable), placing more emphasis on downward variations and rewarding
consistent performance. Managed products; including open-end mutual funds, closed-end funds and exchange-traded funds; are considered a single population for comparative purposes. The top 10% of products in
each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a
managed product is derived from a weighted average of the performance figures associated with its 3-, 5-,and 10-year (if applicable) Morningstar Rating metrics. ©
Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be
accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future
results. The fund represents a single portfolio with multiple share classes that have different expense structures. Other share classes may have achieved different results.
Lipper Rankings
-
1 Year
75 out of 171 -
3 Year
87 out of 159 -
5 Year
74 out of 144 -
10 Year
41 out of 95
LIPPER CLASSIFICATION
Main Risks
The fund uses an indexing strategy. It does not attempt to manage market volatility, use defensive strategies or reduce the effects of any long-term periods of poor stock performance.
Recent market risks include pandemic risks related to COVID-19. The effects of COVID-19 have contributed to increased volatility in global markets and will likely affect certain countries, companies, industries and market sectors more dramatically than others. To the extent the fund may overweight its investments in certain countries, companies, industries or market sectors, such positions will increase the fund's exposure to risk of loss from adverse developments affecting those countries, companies, industries or sectors.
Risk Metrics
As of 02/28/23 3-Year Trailing | Standard Deviation | Alpha | Beta | R-Squared | Sharpe Ratio |
---|---|---|---|---|---|
DIISX
|
20.64 | 0.74 | 1.03 | 95.58 | 0.34 |
All risk metrics are provided by Morningstar. The index used in the calculations are determined by Morningstar which may not be the funds primary benchmark. The index Morningstar used for this analysis is MSCI ACWI ex USA Index.
Dividend Schedule
Year | Dividend ($) | Capital Gains ($) |
---|---|---|
2022 | 0.3753 | 0.0000 |
2021 | 0.6886 | 0.0000 |
2020 | 0.3045 | 0.0000 |
2019 | 0.4969 | 0.0000 |
2018 | 0.4004 | 0.0000 |
2017 | 0.3887 | 0.0000 |
2016 | 0.4248 | 0.0000 |
2015 | 0.3186 | 0.0000 |
2014 | 0.4340 | 0.0000 |
2013 | 0.3730 | 0.1890 |
There is no guarantee that the fund will distribute any level annually. Capital gains may be short-term, long-term, or both.
Distributions History
Record Date | Ex-Dividend Date | Payable Date |
Ordinary Non-Qualified Dividends |
Qualified Dividends |
Non-Qualified Short-Term Capital Gain |
Qualified Short-Term Capital Gain |
Long-Term Capital Gain |
Total Distribution |
Reinvest NAV |
---|---|---|---|---|---|---|---|---|---|
12/27/22 | 12/28/22 | 12/28/22 | 0.0000 | 0.3753 | 0.0000 | 0.0000 | 0.0000 | 0.3753 | 16.67 |
Record Date | Ex-Dividend Date | Payable Date |
Ordinary Non-Qualified Dividends |
Qualified Dividends |
Non-Qualified Short-Term Capital Gain |
Qualified Short-Term Capital Gain |
Long-Term Capital Gain |
Total Distribution |
Reinvest NAV |
---|---|---|---|---|---|---|---|---|---|
12/28/21 | 12/29/21 | 12/29/21 | 0.1554 | 0.5332 | 0.0000 | 0.0000 | 0.0000 | 0.6886 | - |
12/28/20 | 12/29/20 | 12/29/20 | 0.0000 | 0.3045 | 0.0000 | 0.0000 | 0.0000 | 0.3045 | - |
12/26/19 | 12/27/19 | 12/27/19 | 0.0000 | 0.4969 | 0.0000 | 0.0000 | 0.0000 | 0.4969 | - |
12/26/18 | 12/27/18 | 12/27/18 | 0.0000 | 0.4004 | 0.0000 | 0.0000 | 0.0000 | 0.4004 | - |
12/21/17 | 12/22/17 | 12/22/17 | 0.0000 | 0.3887 | 0.0000 | 0.0000 | 0.0000 | 0.3887 | - |
12/21/16 | 12/22/16 | 12/22/16 | 0.0000 | 0.4248 | 0.0000 | 0.0000 | 0.0000 | 0.4248 | - |
12/22/15 | 12/23/15 | 12/23/15 | 0.0000 | 0.3186 | 0.0000 | 0.0000 | 0.0000 | 0.3186 | - |
12/22/14 | 12/23/14 | 12/23/14 | 0.0000 | 0.4340 | 0.0000 | 0.0000 | 0.0000 | 0.4340 | - |
12/20/13 | 12/23/13 | 12/23/13 | 0.0000 | 0.3730 | 0.0000 | 0.0000 | 0.1890 | 0.5620 | - |
12/21/12 | 12/24/12 | 12/24/12 | 0.0000 | 0.3940 | 0.0000 | 0.0000 | 0.0000 | 0.3940 | - |
12/22/11 | 12/23/11 | 12/23/11 | 0.0000 | 0.4392 | 0.0000 | 0.0000 | 0.0000 | 0.4392 | - |
12/23/10 | 12/27/10 | 12/27/10 | 0.0000 | 0.3254 | 0.0000 | 0.0000 | 0.0000 | 0.3254 | - |
See all rows... |
Literature
Factsheet, Prospectus and Reports
- Download
- Share
- Subscribe
- Order